ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
August 2025
Fusion Science and Technology
Latest News
Chris Wagner: The role of Eden Radioisotopes in the future of nuclear medicine
Chris Wagner has more than 40 years of experience in nuclear medicine, beginning as a clinical practitioner before moving into leadership roles at companies like Mallinckrodt (now Curium) and Nordion. His knowledge of both the clinical and the manufacturing sides of nuclear medicine laid the groundwork for helping to found Eden Radioisotopes, a start-up venture that intends to make diagnostic and therapeutic raw material medical isotopes like molybdenum-99 and lutetium-177.
H. Y. Khater, R. T. Santoro
Fusion Science and Technology | Volume 30 | Number 3 | December 1996 | Pages 1528-1532
Safety and Environment | doi.org/10.13182/FST96-A11963167
Articles are hosted by Taylor and Francis Online.
Two-dimensional biological dose rates were calculated at different locations outside the International Thermonuclear Experimental Reactor (ITER) design. An 18° sector of the reactor was modeled in r-Θ geometry. The calculations were performed for three different pulsing scenarios. This included a single pulse of 1000 s duration, 10 pulses of 1000 s duration with a 50% duty factor, and 9470 pulses of 1000 s duration with a 50% duty factor for a total fluence of 0.3 MW˙a/m2. The dose rates were calculated as a function of toroidal angle at locations in the space between the toroidal field (TF) coils and cryostat, and in the space between the cryostat and the biological shield. The two-dimensional results clearly showed the toroidal effect, which is dominated by contribution from the activation of the cryostat and the biological shield. After one pulse, full access to the machine is possible within a few hours following shutdown. After 10 pulses, full access is also possible within the first day following shutdown. At the end of the Basic Performance Phase (BPP), full access is possible at any of the locations considered after one week following shutdown.